In the last couple of weeks, we’ve explored what was said about Medicare Part D costs, beneficiary premiums and competition when the program was created – and at what has actually happened in the first 10 years of the program.
This week, we’re wrapping up our Part D then and now with a closer look at coverage.
Watch our video on how patients benefit from Part D coverage for more.
Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004
Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how
"1. Information Collection."